📣 We are thrilled to announce @denadubal.bsky.social is joining our Executive Committee! Dr. Dubal's research investigates the molecular mechanisms of #aging, #resilience, and #neurodegenerative_disease. #SciSky #GeroSky
June 13, 2025 at 10:24 PM
📣 We are thrilled to announce @denadubal.bsky.social is joining our Executive Committee! Dr. Dubal's research investigates the molecular mechanisms of #aging, #resilience, and #neurodegenerative_disease. #SciSky #GeroSky
Disappointing, but not surprising. The observation that active individuals exhibited later #dementia or #neurodegenerative_disease concluded activity was causal/beneficial. It was just as likely that the (in)ability to be active is a biomarker related to age-of-onset.
October 10, 2023 at 9:21 PM
Disappointing, but not surprising. The observation that active individuals exhibited later #dementia or #neurodegenerative_disease concluded activity was causal/beneficial. It was just as likely that the (in)ability to be active is a biomarker related to age-of-onset.
Cumulus Neuroscience's NeuLogiq Platform: A Breakthrough for At-Home Cognitive Assessment in ALS and FTD#United_States#Dublin#Neurodegenerative_Disease#NeuLogiq#ALS-FTD_Study
Cumulus Neuroscience's NeuLogiq Platform: A Breakthrough for At-Home Cognitive Assessment in ALS and FTD
Cumulus Neuroscience's NeuLogiq platform demonstrates feasibility for at-home cognitive assessments in ALS and FTD patients, as revealed in a new study.
third-news.com
August 20, 2026 at 6:16 AM
Cumulus Neuroscience's NeuLogiq Platform: A Breakthrough for At-Home Cognitive Assessment in ALS and FTD#United_States#Dublin#Neurodegenerative_Disease#NeuLogiq#ALS-FTD_Study
Jeffrey Kasten Takes the Helm as Chief Business Officer at Vertero Therapeutics#USA#Neurodegenerative_Disease#South_Riding#Jeffrey_Kasten#Vertero_Therapeutics
Jeffrey Kasten Takes the Helm as Chief Business Officer at Vertero Therapeutics
Jeffrey Kasten has been appointed as Chief Business Officer at Vertero Therapeutics, focusing on strategic growth and partnerships for neurodegenerative therapies.
third-news.com
December 17, 2025 at 9:10 AM
Jeffrey Kasten Takes the Helm as Chief Business Officer at Vertero Therapeutics#USA#Neurodegenerative_Disease#South_Riding#Jeffrey_Kasten#Vertero_Therapeutics
Accelerating Neurodegenerative Disease Research Through Groundbreaking Collaboration#USA#New_York#Neurodegenerative_Disease#NYSCF#Janssen_Research
Accelerating Neurodegenerative Disease Research Through Groundbreaking Collaboration
The New York Stem Cell Foundation has partnered with Janssen Research to enhance precision drug discovery for neurodegenerative diseases using AI-powered systems.
third-news.com
January 10, 2025 at 12:02 PM
Accelerating Neurodegenerative Disease Research Through Groundbreaking Collaboration#USA#New_York#Neurodegenerative_Disease#NYSCF#Janssen_Research